期刊文献+

阿托伐他汀与洛伐他汀对老年高血脂症强化降脂治疗的疗效和安全性研究 被引量:8

COMPARATIVE STUDY OF EFFECTS AND SAFETY OF ATORVASTATIN AND LOVASTATIN ON AGED PATIENTS WITH HYPERLIPIDEMIA
下载PDF
导出
摘要 目的观察阿托伐他汀与洛伐他汀治疗老年高血脂症患者的疗效及安全性。方法将112例老年高血脂症患者随机分成A、B两组,各56例。A组:给予阿托伐他汀,10 mg/d;B组:给予洛伐他汀,20 mg/d。治疗前、治疗第6周后检查两组患者血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)、谷丙转氨酶(ALT)、肌酸磷酸激酶(CK)。结果两组均能显著降低TC、LDL-C、TG,升高HDL-C(P<0.05),A组作用强于B组(P<0.05)。两组均有良好的安全性。结论阿托伐他汀与洛伐他汀均能有效调整老年患者血脂水平,阿托伐他汀作用明显优于洛伐他汀,两者均有好的安全性。 Objective To investigate the efects and the safety of atorvastatin and lovastatin on aged patients with hyperlipidemia.Methods 112 patients were randomly divided into two groups.56 in Group A were given orally atorvastatin 10 mg/d,and 56 in the Group B were given lovastatin 20 mg/d orally,respectively.The levels of serum total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C)and triglyceride(TG)were measured in the 6th week.And the changes of the levels of alanine aminotransferase(ALT) and the creatine phosphokinase(CPK) in the two groups before and after the treatments were also observed.Results In the 6th week,the levels of TCH,the LDL-C,the TG and HDL-C was significantly reduced in both groups.The reliability in both two groups was good.Conclusion Both atorvastatin and lovastatin 2 are effective and reliable in the treatment of Hyperlipidemia,with atorvastatin superior to lovastatin in therapeutic effects.
作者 王其柱
出处 《山东医学高等专科学校学报》 2011年第3期185-186,189,共3页 Journal of Shandong Medical College
关键词 阿托伐他汀 洛伐他汀 高血脂症 老年人 Atorvastatin Lovastatin Hyperlipidemia Aged
  • 相关文献

参考文献7

  • 1LaRosa JC,J Vupputuri HS.Effect of statin on risk of coronary disease:A meta-analysis of randomized controlled trails[J].JAMA,1999,282(32):2340-2346.
  • 2Steinberg D,Gotto AM Jr.Preventing coronary artery disease by lowering cholesterol levels:Fifty years from bench to bedside[J].JAMA,1999,282(21):2043-2050.
  • 3LaRosa JC,Hunninghake D,Bush D,et al.The cholesterol facts.A summary of the evidence relating dietary fats,serum cholesterol,and coronary heart disease.A joint statement by the American Heart Association and the National Heart,Lung,and Blood Institute.The Task Force on Cholesterol Issues,American Heart Association[J].Circulation,1990,81(5):1721-1733.
  • 4Schoonjans K,Peinado-Onsurbe J,Fruchart JC,et al.3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase[J].FEBS Lett,1999,452(3):160-164.
  • 5舒华,高凤荣,贾素兰.小剂量阿托伐他汀对老年冠心病患者强化降脂治疗的疗效及安全性观察[J].内蒙古医学杂志,2007,39(12):1433-1435. 被引量:12
  • 6张文斌,宋筱筱,傅国胜,蔡思宇.他汀类药物临床研究进展[J].心血管病学进展,2006,27(1):79-82. 被引量:40
  • 7赵水平.强化降脂治疗的临床应用和意义[J].基础医学与临床,2006,26(2):113-117. 被引量:15

二级参考文献35

  • 1Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipidlowering therapy on plaque volume and composition in patients with coronary artery disease[J]. Circulation, 2001, 104(4): 387 - 392.
  • 2Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques : implications for plaque stabilization [ J ]. Circulation,2001,103(7) : 926 - 933.
  • 3Takano M, Mizuno K, Yokoyama S, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy[J]. J Am Coil Cardiol, 2003, 42(4): 680- 686.
  • 4Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival [ J]. JAMA, 2001,285:430 - 436.
  • 5Spencer FA, Allegrone J, Goldberg RJ, et al. Association of statin therapy with outcomes of acute coronary syndrome: the GRACE study[J]. Ann Intern Med, 2004,140:857- 866.
  • 6Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastain on early recurrent ischemic events in acute ccoronary syndromes- the MIRACLE study. Arandomized controlled trial[J]. JAMA, 2001,285:1711- 1718.
  • 7Cannon CP, I Braunwald E, McCabe C, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J]. N Engl J Med, 2004,350:1495- 1504.
  • 8Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part Ⅰ[J]. Circulation, 2003, 108(14): 1664 - 1672.
  • 9Topoi EJ. Intensive statin therapy-A sea change in cardiovascular prevention[J]. N Engl J Med, 2004,350:1562- 1564.
  • 10LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease[ J]. N Engl J Med, 2005,352 : 1425 - 1435.

共引文献61

同被引文献85

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部